Global CAR T-Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global CAR T-Cell Therapy market size was valued at USD 1770.5 million in 2023 and is forecast to a readjusted size of USD 10330 million by 2030 with a CAGR of 28.7% during review period.

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.

The global top three CAR T-Cell therapy players include Novartis, Gilead Sciences, Bristol-Myers Squibb, with a total market share of more than 99%. The largest player is Gilead Sciences, with a market share of over 50%. North America is the global most important consumer market for CAR T-Cell therapy, with a market share of more than 65%. In terms of type, CD19-targeted CAR cell therapy has a market share of over 90%. In the field of application, the market share of lymphoma exceeds 90%.

The Global Info Research report includes an overview of the development of the CAR T-Cell Therapy industry chain, the market status of Lymphoma (CD19 - Targeted, BCMA - Targeted), Multiple Myeloma (CD19 - Targeted, BCMA - Targeted), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CAR T-Cell Therapy.

Regionally, the report analyzes the CAR T-Cell Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CAR T-Cell Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the CAR T-Cell Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CAR T-Cell Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CD19 - Targeted, BCMA - Targeted).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CAR T-Cell Therapy market.

Regional Analysis: The report involves examining the CAR T-Cell Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CAR T-Cell Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to CAR T-Cell Therapy:
Company Analysis: Report covers individual CAR T-Cell Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CAR T-Cell Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Lymphoma, Multiple Myeloma).

Technology Analysis: Report covers specific technologies relevant to CAR T-Cell Therapy. It assesses the current state, advancements, and potential future developments in CAR T-Cell Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CAR T-Cell Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
CAR T-Cell Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    CD19 - Targeted
    BCMA - Targeted

Market segment by Application
    Lymphoma
    Multiple Myeloma

Market segment by players, this report covers
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite
    CARsgen Therapeutics (Pipeline)
    Autolus Therapeutics(Pipeline)
    Sorrento Therapeutics(Pipeline)
    Mustang Bio(Pipeline)
    Bluebird Bio(Pipeline)
    Cellectis(Pipeline)
    Allogene Therapeutics(Pipeline)
    Celyad(Pipeline)

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CAR T-Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR T-Cell Therapy, with revenue, gross margin and global market share of CAR T-Cell Therapy from 2019 to 2024.
Chapter 3, the CAR T-Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CAR T-Cell Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-Cell Therapy.
Chapter 13, to describe CAR T-Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of CAR T-Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of CAR T-Cell Therapy by Type
        1.3.1 Overview: Global CAR T-Cell Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global CAR T-Cell Therapy Consumption Value Market Share by Type in 2023
        1.3.3 CD19 - Targeted
        1.3.4 BCMA - Targeted
    1.4 Global CAR T-Cell Therapy Market by Application
        1.4.1 Overview: Global CAR T-Cell Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Lymphoma
        1.4.3 Multiple Myeloma
    1.5 Global CAR T-Cell Therapy Market Size & Forecast
    1.6 Global CAR T-Cell Therapy Market Size and Forecast by Region
        1.6.1 Global CAR T-Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global CAR T-Cell Therapy Market Size by Region, (2019-2030)
        1.6.3 North America CAR T-Cell Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe CAR T-Cell Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific CAR T-Cell Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America CAR T-Cell Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa CAR T-Cell Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis CAR T-Cell Therapy Product and Solutions
        2.1.4 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences CAR T-Cell Therapy Product and Solutions
        2.2.4 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Gilead Sciences Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb
        2.3.1 Bristol-Myers Squibb Details
        2.3.2 Bristol-Myers Squibb Major Business
        2.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Product and Solutions
        2.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.4 J & J
        2.4.1 J & J Details
        2.4.2 J & J Major Business
        2.4.3 J & J CAR T-Cell Therapy Product and Solutions
        2.4.4 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 J & J Recent Developments and Future Plans
    2.5 JW Therapeutics
        2.5.1 JW Therapeutics Details
        2.5.2 JW Therapeutics Major Business
        2.5.3 JW Therapeutics CAR T-Cell Therapy Product and Solutions
        2.5.4 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 JW Therapeutics Recent Developments and Future Plans
    2.6 FOSUNKite
        2.6.1 FOSUNKite Details
        2.6.2 FOSUNKite Major Business
        2.6.3 FOSUNKite CAR T-Cell Therapy Product and Solutions
        2.6.4 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 FOSUNKite Recent Developments and Future Plans
    2.7 CARsgen Therapeutics (Pipeline)
        2.7.1 CARsgen Therapeutics (Pipeline) Details
        2.7.2 CARsgen Therapeutics (Pipeline) Major Business
        2.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product and Solutions
        2.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
    2.8 Autolus Therapeutics(Pipeline)
        2.8.1 Autolus Therapeutics(Pipeline) Details
        2.8.2 Autolus Therapeutics(Pipeline) Major Business
        2.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
        2.8.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Autolus Therapeutics(Pipeline) Recent Developments and Future Plans
    2.9 Sorrento Therapeutics(Pipeline)
        2.9.1 Sorrento Therapeutics(Pipeline) Details
        2.9.2 Sorrento Therapeutics(Pipeline) Major Business
        2.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
        2.9.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Sorrento Therapeutics(Pipeline) Recent Developments and Future Plans
    2.10 Mustang Bio(Pipeline)
        2.10.1 Mustang Bio(Pipeline) Details
        2.10.2 Mustang Bio(Pipeline) Major Business
        2.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
        2.10.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Mustang Bio(Pipeline) Recent Developments and Future Plans
    2.11 Bluebird Bio(Pipeline)
        2.11.1 Bluebird Bio(Pipeline) Details
        2.11.2 Bluebird Bio(Pipeline) Major Business
        2.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
        2.11.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Bluebird Bio(Pipeline) Recent Developments and Future Plans
    2.12 Cellectis(Pipeline)
        2.12.1 Cellectis(Pipeline) Details
        2.12.2 Cellectis(Pipeline) Major Business
        2.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Product and Solutions
        2.12.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Cellectis(Pipeline) Recent Developments and Future Plans
    2.13 Allogene Therapeutics(Pipeline)
        2.13.1 Allogene Therapeutics(Pipeline) Details
        2.13.2 Allogene Therapeutics(Pipeline) Major Business
        2.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
        2.13.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Allogene Therapeutics(Pipeline) Recent Developments and Future Plans
    2.14 Celyad(Pipeline)
        2.14.1 Celyad(Pipeline) Details
        2.14.2 Celyad(Pipeline) Major Business
        2.14.3 Celyad(Pipeline) CAR T-Cell Therapy Product and Solutions
        2.14.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Celyad(Pipeline) Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global CAR T-Cell Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of CAR T-Cell Therapy by Company Revenue
        3.2.2 Top 3 CAR T-Cell Therapy Players Market Share in 2023
        3.2.3 Top 6 CAR T-Cell Therapy Players Market Share in 2023
    3.3 CAR T-Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 CAR T-Cell Therapy Market: Region Footprint
        3.3.2 CAR T-Cell Therapy Market: Company Product Type Footprint
        3.3.3 CAR T-Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global CAR T-Cell Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global CAR T-Cell Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global CAR T-Cell Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America CAR T-Cell Therapy Consumption Value by Type (2019-2030)
    6.2 North America CAR T-Cell Therapy Consumption Value by Application (2019-2030)
    6.3 North America CAR T-Cell Therapy Market Size by Country
        6.3.1 North America CAR T-Cell Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico CAR T-Cell Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe CAR T-Cell Therapy Consumption Value by Type (2019-2030)
    7.2 Europe CAR T-Cell Therapy Consumption Value by Application (2019-2030)
    7.3 Europe CAR T-Cell Therapy Market Size by Country
        7.3.1 Europe CAR T-Cell Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        7.3.3 France CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy CAR T-Cell Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2019-2030)
        8.3.2 China CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.5 India CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia CAR T-Cell Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America CAR T-Cell Therapy Consumption Value by Type (2019-2030)
    9.2 South America CAR T-Cell Therapy Consumption Value by Application (2019-2030)
    9.3 South America CAR T-Cell Therapy Market Size by Country
        9.3.1 South America CAR T-Cell Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina CAR T-Cell Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia CAR T-Cell Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE CAR T-Cell Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 CAR T-Cell Therapy Market Drivers
    11.2 CAR T-Cell Therapy Market Restraints
    11.3 CAR T-Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 CAR T-Cell Therapy Industry Chain
    12.2 CAR T-Cell Therapy Upstream Analysis
    12.3 CAR T-Cell Therapy Midstream Analysis
    12.4 CAR T-Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global CAR T-Cell Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global CAR T-Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global CAR T-Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Novartis Company Information, Head Office, and Major Competitors
    Table 6. Novartis Major Business
    Table 7. Novartis CAR T-Cell Therapy Product and Solutions
    Table 8. Novartis CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Novartis Recent Developments and Future Plans
    Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 11. Gilead Sciences Major Business
    Table 12. Gilead Sciences CAR T-Cell Therapy Product and Solutions
    Table 13. Gilead Sciences CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Gilead Sciences Recent Developments and Future Plans
    Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 16. Bristol-Myers Squibb Major Business
    Table 17. Bristol-Myers Squibb CAR T-Cell Therapy Product and Solutions
    Table 18. Bristol-Myers Squibb CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 20. J & J Company Information, Head Office, and Major Competitors
    Table 21. J & J Major Business
    Table 22. J & J CAR T-Cell Therapy Product and Solutions
    Table 23. J & J CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. J & J Recent Developments and Future Plans
    Table 25. JW Therapeutics Company Information, Head Office, and Major Competitors
    Table 26. JW Therapeutics Major Business
    Table 27. JW Therapeutics CAR T-Cell Therapy Product and Solutions
    Table 28. JW Therapeutics CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. JW Therapeutics Recent Developments and Future Plans
    Table 30. FOSUNKite Company Information, Head Office, and Major Competitors
    Table 31. FOSUNKite Major Business
    Table 32. FOSUNKite CAR T-Cell Therapy Product and Solutions
    Table 33. FOSUNKite CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. FOSUNKite Recent Developments and Future Plans
    Table 35. CARsgen Therapeutics (Pipeline) Company Information, Head Office, and Major Competitors
    Table 36. CARsgen Therapeutics (Pipeline) Major Business
    Table 37. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product and Solutions
    Table 38. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
    Table 40. Autolus Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
    Table 41. Autolus Therapeutics(Pipeline) Major Business
    Table 42. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
    Table 43. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Autolus Therapeutics(Pipeline) Recent Developments and Future Plans
    Table 45. Sorrento Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
    Table 46. Sorrento Therapeutics(Pipeline) Major Business
    Table 47. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
    Table 48. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Sorrento Therapeutics(Pipeline) Recent Developments and Future Plans
    Table 50. Mustang Bio(Pipeline) Company Information, Head Office, and Major Competitors
    Table 51. Mustang Bio(Pipeline) Major Business
    Table 52. Mustang Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
    Table 53. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Mustang Bio(Pipeline) Recent Developments and Future Plans
    Table 55. Bluebird Bio(Pipeline) Company Information, Head Office, and Major Competitors
    Table 56. Bluebird Bio(Pipeline) Major Business
    Table 57. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product and Solutions
    Table 58. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Bluebird Bio(Pipeline) Recent Developments and Future Plans
    Table 60. Cellectis(Pipeline) Company Information, Head Office, and Major Competitors
    Table 61. Cellectis(Pipeline) Major Business
    Table 62. Cellectis(Pipeline) CAR T-Cell Therapy Product and Solutions
    Table 63. Cellectis(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Cellectis(Pipeline) Recent Developments and Future Plans
    Table 65. Allogene Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors
    Table 66. Allogene Therapeutics(Pipeline) Major Business
    Table 67. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions
    Table 68. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Allogene Therapeutics(Pipeline) Recent Developments and Future Plans
    Table 70. Celyad(Pipeline) Company Information, Head Office, and Major Competitors
    Table 71. Celyad(Pipeline) Major Business
    Table 72. Celyad(Pipeline) CAR T-Cell Therapy Product and Solutions
    Table 73. Celyad(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 74. Celyad(Pipeline) Recent Developments and Future Plans
    Table 75. Global CAR T-Cell Therapy Revenue (USD Million) by Players (2019-2024)
    Table 76. Global CAR T-Cell Therapy Revenue Share by Players (2019-2024)
    Table 77. Breakdown of CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 78. Market Position of Players in CAR T-Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 79. Head Office of Key CAR T-Cell Therapy Players
    Table 80. CAR T-Cell Therapy Market: Company Product Type Footprint
    Table 81. CAR T-Cell Therapy Market: Company Product Application Footprint
    Table 82. CAR T-Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 83. CAR T-Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 84. Global CAR T-Cell Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 85. Global CAR T-Cell Therapy Consumption Value Share by Type (2019-2024)
    Table 86. Global CAR T-Cell Therapy Consumption Value Forecast by Type (2025-2030)
    Table 87. Global CAR T-Cell Therapy Consumption Value by Application (2019-2024)
    Table 88. Global CAR T-Cell Therapy Consumption Value Forecast by Application (2025-2030)
    Table 89. North America CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 90. North America CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 91. North America CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 92. North America CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 93. North America CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 94. North America CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 95. Europe CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 96. Europe CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 97. Europe CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 98. Europe CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 99. Europe CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 100. Europe CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 101. Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 102. Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 103. Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 104. Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 105. Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 106. Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 107. South America CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 108. South America CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 109. South America CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 110. South America CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 111. South America CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 112. South America CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 113. Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 114. Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 115. Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 116. Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 117. Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 118. Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 119. CAR T-Cell Therapy Raw Material
    Table 120. Key Suppliers of CAR T-Cell Therapy Raw Materials
List of Figures
    Figure 1. CAR T-Cell Therapy Picture
    Figure 2. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global CAR T-Cell Therapy Consumption Value Market Share by Type in 2023
    Figure 4. CD19 - Targeted
    Figure 5. BCMA - Targeted
    Figure 6. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. CAR T-Cell Therapy Consumption Value Market Share by Application in 2023
    Figure 8. Lymphoma Picture
    Figure 9. Multiple Myeloma Picture
    Figure 10. Global CAR T-Cell Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global CAR T-Cell Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Market CAR T-Cell Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 13. Global CAR T-Cell Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 14. Global CAR T-Cell Therapy Consumption Value Market Share by Region in 2023
    Figure 15. North America CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 16. Europe CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 17. Asia-Pacific CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 18. South America CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Middle East and Africa CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Global CAR T-Cell Therapy Revenue Share by Players in 2023
    Figure 21. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 22. Global Top 3 Players CAR T-Cell Therapy Market Share in 2023
    Figure 23. Global Top 6 Players CAR T-Cell Therapy Market Share in 2023
    Figure 24. Global CAR T-Cell Therapy Consumption Value Share by Type (2019-2024)
    Figure 25. Global CAR T-Cell Therapy Market Share Forecast by Type (2025-2030)
    Figure 26. Global CAR T-Cell Therapy Consumption Value Share by Application (2019-2024)
    Figure 27. Global CAR T-Cell Therapy Market Share Forecast by Application (2025-2030)
    Figure 28. North America CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 29. North America CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 30. North America CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 31. United States CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 32. Canada CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 33. Mexico CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 34. Europe CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 35. Europe CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 36. Europe CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 37. Germany CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 38. France CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 39. United Kingdom CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 40. Russia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 41. Italy CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 42. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 43. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 44. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 45. China CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 46. Japan CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 47. South Korea CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 48. India CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 49. Southeast Asia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 50. Australia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. South America CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 52. South America CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 53. South America CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 54. Brazil CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 55. Argentina CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 56. Middle East and Africa CAR T-Cell Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 57. Middle East and Africa CAR T-Cell Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 58. Middle East and Africa CAR T-Cell Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 59. Turkey CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 60. Saudi Arabia CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 61. UAE CAR T-Cell Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 62. CAR T-Cell Therapy Market Drivers
    Figure 63. CAR T-Cell Therapy Market Restraints
    Figure 64. CAR T-Cell Therapy Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of CAR T-Cell Therapy in 2023
    Figure 67. Manufacturing Process Analysis of CAR T-Cell Therapy
    Figure 68. CAR T-Cell Therapy Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Companies Mentioned

Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)